PMV Pharmaceuticals
VC Fund
Redwood City, United States
PMV Pharmaceuticals is a VC fund in Redwood City focused on Health Care and Biotechnology. PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries PMV Pharmaceuticals invests in
Stages PMV Pharmaceuticals invests in
Countries PMV Pharmaceuticals invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Arnold Levine
|
|||
David Mack
|
|||
Leila Alland
|
|||
Thomas Shenk
|
|||
Tim Smith
|
Investment Focus
Industry
- Health Care 2 (100%)
- Biotechnology 2 (100%)
- Medical 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Country
- United Kingdom 1 (50%)
- The Netherlands 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Arnold Levine
Co-Founder
|
Co-Founder | Total investments: 0 | Find email | |
|
David Mack
President & CEO
|
President & CEO | Total investments: 0 | Find email | |
|
Leila Alland
Chief Medical Officer
|
Chief Medical Officer | Total investments: 0 | Find email | |
|
Thomas Shenk
Co-Founder & Member, Scientific Advisory Board
|
Co-Founder & Member, Scientific Advisory Board | Total investments: 0 | Find email | |
|
Tim Smith
SVP, Head of Corporate Development
|
SVP, Head of Corporate Development | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Apitope
|
Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, Factor VIII intolerance and uveitis. The company, whose first product candidate is licensed to Merck Serono, will now progress its remaining portfolio of productcandidates developed with its proprietary platform technology. | $13.2M / Series B / Sep 29, 2015 | |
FF Pharma
|
FF Pharma, a biopharmaceutical company, develops anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases like primary biliary cirrhosis and Crohn’s disease. The functions of CD40 in immune regulation suggest that the CD40 pathway may play a role in diseases in which anomalous immune responses, e.g. autoantibodyproduction or chronic inflammation, are a feature. | $4.2M / Series A / Jan 23, 2013 |
Co-Investors
Limburgse Reconversie Maatschappij
2 deals together
Vesalius Biocapital Partners
2 deals together
Arthurian Life Sciences
1 deal together
Wyvern Seed Fund
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does PMV Pharmaceuticals invest in?
PMV Pharmaceuticals invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact PMV Pharmaceuticals?
Public channels for PMV Pharmaceuticals include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at PMV Pharmaceuticals?
The team at PMV Pharmaceuticals includes Arnold Levine (Co-Founder), David Mack (President & CEO) and Leila Alland (Chief Medical Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
